Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for February 2015

    ... and chronic GVHD within 6 months and 2 years. 3.    Engraftment at 6 months, 1 year and 2 years This study is being ...

    Page last updated 01/29/2015 - 10:10am.

  2. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... with malignant and non-malignant disease with successful engraftment and has shown some improvement in GVHD. It is unknown if CD34+ ...

    Clinical Trial last updated 04/27/2016 - 8:55am.

  3. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... percent or if the combined event rate for failed donor engraftment or treatment related mortality (TRM) at day 100 exceeds 20 ... Secondary end points include transplant related mortality, engraftment, degree of donor-host chimerism, incidence of acute and chronic ...

    Clinical Trial last updated 04/25/2016 - 10:08am.

  4. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... percent or if the combined event rate for failed donor engraftment or treatment related mortality (TRM) at day 100 exceeds 20 ... Secondary end points include transplant related mortality, engraftment, degree of donor-host chimerism, incidence of acute and chronic ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  5. Transplants With Unlicensed Preserved Cord Blood

    ... incidence of chronic GVHD Determine CBU-derived engraftment Eligibility Criteria Inclusion Criteria ...

    Clinical Trial last updated 04/27/2016 - 3:20pm.

  6. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... as a source of back-up cells source in case of engraftment failure. Patient Age Criteria: Age > 18 and < 55 years ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  7. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... or other disease known to prolong neutrophil engraftment to > 28 days after transplant. Must not be receiving any ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  8. Clinical Trials Report for April 2014

    ... outcomes measures include transplant related mortality, engraftment , degree of donor-host chimerism, incidence of acute and ...

    Page last updated 04/18/2014 - 3:36pm.

  9. Transplantation

     

    Page last updated 01/20/2015 - 4:45pm.

  10. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... that would jeopardize donor hematopoietic cell engraftment ; this determination is based on the standard practice of the ...

    Clinical Trial last updated 04/28/2016 - 2:45pm.